HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
A Better Way to Make Money in Today's Market
Learn more now >>
Quote:
Login Free Membership
Search:

 
Analyst Blog  

AOB Has the Herbal Remedy

November 11, 2008 | Comments: 0
Recommended this article (1)
AOB
Print    Share

American Oriental Bioengineering Inc. (AOB - Snapshot Report) is a China-based specialty pharmaceutical company which develops, manufactures and commercializes both plant-based pharmaceutical (PBP) and plant-based nutraceutical (PBN) products. Third quarter financials were strong and in line with our expectations.

We expect the company to continue to deliver strong performances in the coming quarters due to relatively high growth in the Traditional Chinese Medicine market in China. We maintain our Buy rating on AOB with a price target of $16.

PBPs are Traditional Chinese Medicines (TCM) based on non-synthetic medicinal compounds that are extracted from leaves and roots of one or more plants. Each PBP has certain medicinal functions and proven efficacy in the treatment of at least one or more illnesses or symptoms of illnesses. PBNs, also frequently referred to as "dietary supplements" or "nutritional supplements," are prophylactic or preventive, in contrast to PBP products which are used to treat an illness or symptoms of an illness.

Read the full analyst report on AOB


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (1)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!

More Zacks Resources

Market Summary Nov 08, 2009 04:08 am ET
DJIA 10023.42  17.46 0.17%
NASD 2112.44  7.12 0.34%
S&P 500 1069.3  2.67 0.25%
Sponsored Links